Prednisone with early ART in HIV-TB
Not Applicable
- Conditions
- HIV/AIDSTuberculosis
- Registration Number
- PACTR201304000511413
- Lead Sponsor
- niversity of Cape Town
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
HIV infection
CD 4 count equal to or less than 100 cells/microlitre
ART naieve
Confirmed diagnosis of TB
On TB treatment for less than 30 days prior to study entry
Eligible for ART and consent to start ART within 30 days of starting TB treatment
Written informed consent for trial
Exclusion Criteria
Kaposi's sarcoma
Pregnancy
Younger than 18 years of age
TB Meningitis or tuberculoma at TB diagnosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method